Ruthenium Complexes Comprising an Asymmetrical Unsaturated N-Heterocyclic Diaminocarbene
US-2015315223-A1 · Nov 5, 2015 · US
US11241680B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11241680-B2 |
| Application number | US-201816014615-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 21, 2018 |
| Priority date | Oct 29, 2012 |
| Publication date | Feb 8, 2022 |
| Grant date | Feb 8, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The invention is directed to ruthenium-based metathesis catalysts of the Grubbs-Hoveyda type. The new 2-aryloxy-substituted ruthenium catalysts described herein reveal rapid initiation behavior. Further, the corresponding styrene-based precursor compounds are disclosed. The catalysts are prepared in a cross-metathesis reaction starting from styrene-based precursors which can be prepared in a cost-effective manner. The new Grubbs-Hoveyda type catalysts are suitable to catalyze ring-closing metathesis (RCM), cross metathesis (CM) and ring-opening metathesis polymerization (ROMP). Low catalyst loadings are necessary to convert a wide range of substrates including more complex and critical substrates via metathesis reactions at low to moderate temperatures in high yields within short reaction times.
Opening claim text (preview).
The invention claimed is: 1. A compound of formula (I) for the preparation of ruthenium-based catalysts wherein a, b, c and d are, independently from each other, selected from hydrogen, straight chain or branched alkyl groups including C 1 -C 10 -alkyl, C 1 -C 10 -alkoxy, C 1 -C 10 -alkylthio, C 1 -C 10 -silyloxy, C 1 -C 10 -alkylamino, optionally substituted C 6 -C 14 -aryl, optionally substituted C 6 -C 14 -aryloxy, optionally substituted C 6 -C 14 -heteroaryl; R 1 is hydrogen, straight chain or branched C 1 -C 10 -alkylthio, C 1 -C 10 -silyloxy, C 1 -C 10 -alkylamino, C 1 -C 10 -dialkylamino, or electron-withdrawing groups (EWG) selected from the group consisting of trifluormethyl (—CF 3 ), nitro (—NO 2 ), formyl (—CHO), C 1 -C 10 -carboxyl, C 1 -C 10 -alkylamido, C 1 -C 10 -aminocarbonyl, nitrile (—CN) or C 1 -C 10 -sulfonamide; R 2 is hydrogen, straight chain or branched C 1 -C 10 -alkyl groups. 2. The compound according to claim 1 , wherein a, b, c and d each are hydrogen; R 1 is dimethylamino (NMe 2 -), nitro (NO 2 —); and R 2 is hydrogen, methyl, ethyl, n-propyl, iso-propyl, n-butyl or iso-butyl. 3. The compound according to claim 2 , having the formula (Ia) 4. A method for preparing the catalyst according to claim 1 , comprising reacting a compound of formula (I) wherein a, b, c and d are, independently from each other, selected from hydrogen, straight chain or branched alkyl groups including C 1 -C 10 -alkyl, C 1 -C 10 -alkoxy, C 1 -C 10 -alkylthio, C 1 -C 10 -silyloxy, C 1 -C 10 -alkylamino, optionally substituted C 6 -C 14 -aryl, optionally substituted C 6 -C 14 -aryloxy, optionally substituted C 6 -C 14 -heteroaryl; R 1 is straight chain or branched C 1 -C 10 -alkylthio, C 1 -C 10 -silyloxy, C 1 -C 10 -alkylamino, C 1 -C 10 -dialkylamino, or electron-withdrawing groups (EWG) selected from the group consisting of trifluormethyl (—CF 3 ), nitro (—NO 2 ), formyl (—CHO), C 1 -C 10 -carboxyl, C 1 -C 10 -alkylamido, C 1 -C 10 -aminocarbonyl, nitrile (—CN) or C 1 -C 10 -sulfonamide: R 2 is hydrogen, straight chain or branched C 1 -C 10 -alkyl groups with a Ru-starting compound having the formula (V): in a cross metathesis reaction, wherein L is a phosphine ligand selected from the group of tri-iso-propyl-phosphine, tricyclohexylphosphine (PCy 3 ), tricyclopentylphosphine, cyclohexylphobane, 2,2,4-trimethylpentylphobane or isobutyl-phobane or a NHC ligand selected from the group of 1,3-bis-(2,4,6-trimethylphenyl)-imidazolidine-2-ylidene (“SIMes”), 1,3-bis-(2,6-di-isopropylphenyl)-imidazolidine-2-ylidene (“SIPr”) or 1,3-bis-(2,6-diisopropylphenyl)-imidazoline-2-ylidene (“IPr”) and L′ is a leaving ligand from the group of tri-iso-propylphosphine, tricyclohexylphosphine (PCy 3 ), tricyclopentylphosphine, cyclo-hexylphobane, 2,2,4-trimethylpentyl-phobane, isobutylphobane or substituted or unsubstituted pyridine ligands; X is an anionic ligand selected from the group of halogen anions (Cl − , Br − , I − ). 5. The method for preparing the catalysts according to claim 4 , wherein L is a NHC ligand selected from the group of 1,3-bis-(2,4,6-trimethylphenyl)imidazolidine-2-ylidene (“SIMes”), 1,3-bis-(2,6-di-isopropylphenyl)-imidazolidine-2-ylidene (“SIPr”) or 1,3-bis-(2,6-di-isopropylphenyl)-imidazoline-2-ylidene (“IPr”), L′ is pyridine, X is Cl − .
Complexes comprising two carbene ligands differing from each other, e.g. Grubbs second generation catalysts · CPC title
with only nitrogen as heteroatomic ring members, e.g. 1,3-diarylimidazoline-2-ylidenes · CPC title
Ruthenium · CPC title
Ruthenium compounds · CPC title
Cyclisations via conversion of C-C multiple to single or less multiple bonds, e.g. cycloadditions · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.